Results 101 to 110 of about 115,616 (306)

Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits.

open access: yes, 1990
Platelet-activating factor is a potent mediator of inflammation, which has untoward effects on cerebrovascular and neural elements. While several investigators have reported attenuation of ischemic damage after treatment with antagonists of platelet ...
K U Frerichs   +4 more
core   +1 more source

Magnetic‐Field Control of Surface States in CoFe2O4 Thin Films for Nitrate Electroreduction to Ammonia

open access: yesAdvanced Functional Materials, EarlyView.
Magnetic‐field‐assisted CVD of heterometallic single‐source precursors modulates thin‐film surface electronic structure and interfacial charge transfer. Field‐grown (Cobalt ferrite‐1T)CF‐1T films exhibit stabilized electronic states, lower kinetic barriers, and markedly enhanced nitrate‐to‐ammonia electrocatalysis versus (Cobalt ferrite‐0T) CF‐0T ...
Touraj Karimpour   +11 more
wiley   +1 more source

Platelet activating factor acetylhydrolase is associated with cardiac valvular calcification in dialysis patients

open access: yesTürk Biyokimya Dergisi
The cardiovascular mortality risk is greatly increased in patients with chronic kidney disease (CKD), especially in dialysis patients, due to atherosclerosis.
Bolat Serkan   +6 more
doaj   +1 more source

Semi-synthetic preparation of 1-O-[1'-14C]hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) using plant cell cultures.

open access: yesJournal of Lipid Research, 1985
Incubation of photomixotrophic cell suspension cultures of rape (Brassica napus) and heterotrophic cell suspension cultures of soya (Glycine max) with 1-O-[1'-14C]hexadecyl-sn-glycerol or rac-1-O-[1'-14C]hexadecylglycerol leads in high yield (up to 78 ...
N Weber, H K Mangold
doaj   +1 more source

Disparate effects of adhesion and degranulation of platelets on myocardial and coronary function in postischaemic hearts [PDF]

open access: yes, 1998
Beside the major effect of acute thrombus formation, little is known about the interaction of platelets with the coronary endothelium in an ischaemia–reperfusion situation.
Welsch, Ulrich   +3 more
core   +1 more source

Pickering‐Engineered Microparticles for Magnetically Guided Motion and Light‐Triggered Catalysis

open access: yesAdvanced Functional Materials, EarlyView.
Magnetically responsive wax microparticles stabilized by hematite cubes through the Pickering emulsification strategy are developed, showing controlled size, motion, and light‐activated catalytic activity. Annealing under a magnetic field enhances their mobility and steering.
Chiara Ferlito   +6 more
wiley   +1 more source

Amyloid toxicity and platelet-activating factor signaling.

open access: yes, 2013
Amyloidosis is the accumulation of insoluble proteinaceous aggregates in vivo and is implicated in many neurodegenerative diseases, including Alzheimer's, Huntington's, and Parkinson's diseases.
SIRANGELO, Ivana   +2 more
core   +1 more source

Vorticity‐Driven µ‐Platelet Rotation and Selective Packing for Vertical Thermal–Electrical Interconnects

open access: yesAdvanced Functional Materials, EarlyView.
We introduce a capillary‐filtering‐based particle‐filling (CFPF) process that simultaneously forms vertical thermal pathways and electrical vias within µ‐pores. In situ microfluidic analysis reveals that capillary‐driven velocity gradients generate vorticity that governs µ‐platelet rotation and vertical alignment.
Yujin Mun   +11 more
wiley   +1 more source

Effect of platelet activating factor antagonist treatment on gentamicin nephrotoxicity

open access: yesMediators of Inflammation, 1992
To assess whether PAF could be involved in the gentamicin-induced nephrotoxicity, we have studied the effect of PAF antagonist BN-52021 on renal function in rats after gentamicin (GENTA) treatment.
A. Rodriguez-Barbero   +4 more
doaj   +1 more source

Aspirin induces non-enzymatic formation of platelet-activating factor from lyso platelet-activating factor

open access: yes, 1993
Substantial amounts of platelet-activating factor (PAF) were formed when lysoPAF was mixed with aspirin (e.g. 0.04% of added lysoPAF (200 nmol) was converted to PAF when mixed with aspirin (2 μmol) for 1 h).
Cheng, Neng-neng   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy